Watson Laboratories Inc recalls ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by
Recalled March 27, 2013 · FDA recall D-205-2013 · Watson Laboratories
Hazard
Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) . · FDA Class II
Units
136,720 cartons
Sold at
Nationwide
Description
Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .
Product
ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28
Manufacturer(s)
Watson Laboratories Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →